31
Participants
Start Date
February 1, 2020
Primary Completion Date
November 1, 2022
Study Completion Date
November 1, 2022
Within-subject test of blinded study medications
Within-subject double-blind, double-dummy, study design wherein all participants received all doses in 8-hour outpatient sessions. Primary outcomes assessed during 8-hour outpatient sessions and included laboratory pain testing, subjective reports of drug effects, and cognitive performance, evaluated as a function of study medication condition.
Johns Hopkins University Bayview Medical Campus, Baltimore
National Institute on Drug Abuse (NIDA)
NIH
Johns Hopkins University
OTHER